Peptide and CNS drug design exam

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/227

encourage image

There's no tags or description

Looks like no tags are added yet.

228 Terms

1
New cards

What cells form the blood-brain barrier (BBB)?

A single layer of capillary endothelial cells, surrounded by pericytes and astrocytes.

2
New cards

What structures seal adjacent BBB endothelial cells?

Tight junctions between capillary endothelial cells.

3
New cards

Name two proteins found in BBB tight junctions.

Occludin and claudins.

4
New cards

How does BBB tightness compare with the intestinal barrier?

BBB tight junctions are tighter and restrict drug entry into the brain.

5
New cards

Which neurological conditions are associated with BBB dysfunction?

Stroke, neurodegenerative diseases, immune disorders (e.g. MS), and brain tumors.

6
New cards

What is the brain-to-plasma ratio, Kp?

Kp = Cb/Cp, where Cb is total brain concentration and Cp is total plasma concentration.

7
New cards

What does the free drug hypothesis state?

Only a fraction of the drug is unbound and free in plasma (fu,p) or tissue (fu,b for brain) to diffuse across biological barriers

8
New cards

What do fu,p and fu,b represent?

fu,p is the unbound fraction in plasma; fu,b is the unbound fraction in brain tissue.

9
New cards

What is Kp,uu?

= Cb,u/Cp,u; The ratio of unbound brain concentration to unbound plasma concentration

10
New cards

Why can Kp and Kp,uu differ substantially?

Kp measures total concentrations, whereas Kp,uu accounts for the unbound fractions in plasma and brain.

11
New cards

What does Kp,uu approximately equal to 1 indicate?

Passive transport/equilibrium across the BBB.

12
New cards

What does Kp,uu significantly below 1 indicate?

Net active efflux across the BBB.

13
New cards

What does Kp,uu significantly above 1 indicate?

Net active uptake/transport into the brain.

14
New cards

Which brain compartments are shown in the BBB concentration schematic?

Interstitial fluid (ISF), intracellular fluid (ICF), and cerebrospinal fluid (CSF).

15
New cards

Why may total brain concentration fail to predict CNS pharmacology?

Total brain concentration does not necessarily reflect unbound drug concentration at the relevant site, such as ISF.

16
New cards

Approximately what percentage of drugs cross the BBB?

Less than 2%.

17
New cards

What is the principal passive-diffusion route across the BBB?

Transcellular diffusion through endothelial cells.

18
New cards

How do physicochemical requirements for brain penetration compare with oral absorption?

Brain penetration generally requires more restrictive physicochemical properties.

19
New cards

Which two small-molecule properties are most critical for BBB penetration?

Molecular weight (MW) and hydrogen-bond donors (HBD).

20
New cards

What CNS-critical molecular-weight guideline is given for small molecules?

MW ≤ 470 Da.

21
New cards

What CNS-critical TPSA guideline is given for small molecules?

Topological polar surface area (TPSA) ≤ 90 Ų.

22
New cards

What CNS-critical HBD guideline is given for small molecules?

HBD ≤ 2.

23
New cards

In the brain-exposure chart, what trend occurs as HBD count increases?

The fraction of brain-penetrant compounds decreases markedly as HBD count rises.

24
New cards

What do BP and PR mean in the brain-exposure assessment figure?

brain-penetrant and peripherally restricted.

25
New cards

What transporter classes are present at both BBB and intestinal barriers?

Uptake/influx transporters and efflux transporters.

26
New cards

What do transport proteins, that both the BBB and intestine have, do?

Transport compounds into CNS (BBB) or into blood from intestine

27
New cards

What is the effect of BBB efflux proteins on CNS drug exposure?

They transport drugs out of the brain and can limit CNS penetration.

28
New cards

What is P-glycoprotein also called?

Pgp or multidrug resistance protein 1 (MDR1).

29
New cards

Why is P-glycoprotein important in BBB drug discovery?

It is the most studied BBB efflux protein and can strongly limit brain penetration.

30
New cards

Where is P-glycoprotein expressed?

At both the BBB and intestinal barrier.

31
New cards

How does mouse BBB P-glycoprotein expression compare with human expression?

Mouse BBB Pgp expression is 2.3-fold higher than in humans.

32
New cards

What does BCRP stand for?

Breast cancer resistance protein.

33
New cards

Where is BCRP expressed?

At both the BBB and intestinal barrier.

34
New cards

How does human BCRP expression in brain microvessels compare with Pgp?

It is expressed at comparable levels to Pgp in human brain microvessels.

35
New cards

How does human BCRP expression compare with mouse BCRP expression?

Human expression is 1.85-fold higher than mouse expression.

36
New cards

How does mouse BCRP expression compare with mouse Pgp?

Mouse BCRP expression is about one-third that of Pgp.

37
New cards

What is the probability of launch from Phase I entry for CNS drugs cited in the lecture?

3%, compared with 9% for oncology and 16% for anti-infective agents.

38
New cards

What Alzheimer’s drug-development example illustrates the high failure rate?

From 2002–2012, 244 drugs entered Alzheimer’s clinical trials and only one was FDA-approved (memantine).

39
New cards

What are two structural strategies to improve passive BBB diffusion?

Increase lipophilicity and reduce HBD/TPSA.

40
New cards

How can efflux-mediated restriction of CNS exposure be addressed?

Reduce interaction with P-glycoprotein or other efflux transporters.

41
New cards

What is MPO in CNS drug design?

Multiparameter optimization: scoring/optimizing multiple physicochemical properties associated with CNS exposure.

42
New cards

What are major challenges in CNS drug design beyond BBB penetration?

Incomplete disease biology, disease heterogeneity, identifying disease-modifying targets, limitations of animal models, and finding useful biomarkers.

43
New cards

Why is target identification difficult in neurodegenerative disease?

Disease biology may be incompletely understood, and symptoms can appear after extensive neuronal loss.

44
New cards

What is the distinction between disease-modifying and symptomatic treatment?

Disease-modifying treatment alters disease progression; symptomatic treatment alleviates symptoms without necessarily changing progression.

45
New cards

Which Alzheimer’s target categories were prominent in the slide’s clinical-trial chart?

Amyloid-beta, neurotransmitter receptors, tau, inflammation/immune targets, synaptic plasticity/neuroprotection, and metabolism/bioenergetics.

46
New cards

Which therapeutic strategies for Parkinson’s disease were listed?

Alpha-synuclein targeting, GLP-1 receptor agonists, kinase inhibitors, antioxidants, anti-inflammatory approaches, microbiome approaches, and cell therapy.

47
New cards

What are the broad categories of brain-delivery technologies?

Invasive and non-invasive approaches.

48
New cards

What are some non-invasive brain delivery technologies?

Biological mechanisms such as receptor or adsorptive mediated transcytosis, cell-mediated brain delivery, cell-penetrating peptides, and receptor-mediated BBB opening, as well as intranasal delivery

49
New cards

What is the paracellular BBB pathway?

Movement between adjacent endothelial cells through junctional spaces.

50
New cards

Which molecules can use the paracellular pathway under normal conditions?

Primarily small water-soluble molecules; the pathway is highly restricted by tight junctions.

51
New cards

Is passive diffusion transcellular or paracellular?

Transcellular.

52
New cards

What is transcytosis?

Transport across a cell through uptake on one side, intracellular trafficking, and release on the opposite side.

53
New cards

What are the three mediated-transcytosis mechanisms discussed?

Carrier-mediated, receptor-mediated, and absorptive-mediated transcytosis.

54
New cards

What is carrier-mediated transcytosis (CMT)?

Transport proteins that move essential nutrients across the BBB.

55
New cards

How does a carrier protein transport its substrate?

Substrate binding induces a conformational change in the carrier, moving the substrate across the membrane.

56
New cards

What does the large neutral amino acid transporter carry?

Phenylalanine and other large neutral amino acids.

57
New cards

What CNS drug uses a large neutral amino acid transporter?

L-DOPA.

58
New cards

Why can L-DOPA enter the brain when dopamine cannot?

L-DOPA resembles a transported neutral amino acid; after entering the brain it is decarboxylated to dopamine.

59
New cards

What limits the applicability of CMT for drug delivery?

Transporters generally accept only low-molecular-weight compounds structurally similar to their natural nutrient substrates.

60
New cards

What characteristics make a receptor useful for receptor-mediated transport (RMT)?

High BBB expression, preferably selective expression in brain microvasculature than in peripheral tissues or brain parenchyma, and efficient transcytosis.

61
New cards

Why is receptor expression in brain microvasculature preferred over peripheral tissues or brain parenchyma?

It can improve selectivity for transport across the BBB.

62
New cards

What species difference is noted for transferrin receptor expression?

Transferrin receptor expression in mouse brain microvasculature is 2.5-fold higher than in humans.

63
New cards

What limits the delivery capacity of RMT?

Capacity is limited by receptor expression, potentially restricting use to very potent drugs.

64
New cards

How might RMT drug delivery affect endogenous physiology?

It may interfere with transport or function of the receptor’s endogenous ligand.

65
New cards

What does brain parenchyma mean?

Functional brain tissue.

66
New cards

What are the most common receptor mediated transport targets?

Low-density lipoprotein receptors, transferrin receptor, ion channels, and integrins

67
New cards

What are LRP-1 and LRP-2?

Low-density lipoprotein receptor-related proteins 1 and 2, members of the LDL receptor family.

68
New cards

Where are LRP-1 and LRP-2 expressed?

Both are expressed in the CNS.

69
New cards

What is notable about LRP-1 expression in glioma?

LRP-1 is highly expressed on glioma cells.

70
New cards

How can LRP proteins support brain delivery?

They bind and endocytose a broad range of proteins, enabling cargo transport through transcytosis.

71
New cards

What is the normal function of the transferrin receptor (TfR)?

It mediates transport of transferrin, an iron-binding protein, and regulates iron uptake and homeostasis.

72
New cards

What does transferrin transport across the BBB?

Iron.

73
New cards

How were several TfR-targeting peptides identified?

By phage display.

74
New cards

Which ion channel receptor is targeted for CNS delivery?

The nicotinic acetylcholine receptor, a ligand-gated ion channel expressed in the CNS and peripheral nervous system.

75
New cards

Which other ion channel target is mentioned?

Potassium channels.

76
New cards

Which integrin is listed as an RMT target?

Alpha-v-beta-3 (αvβ3) integrin.

77
New cards

Which receptor does Angiopep-2 bind?

LRP-1.

78
New cards

How does Angiopep-2 facilitate cargo delivery?

Angiopep-2 binds LRP-1; the complex is internalized and cargo can be transported across the BBB.

79
New cards

What types of cargo have been attached to Angiopep-2?

Small molecules and peptides, including neurotensin; it has also been used to modify nanoparticles.

80
New cards

What is ANG1005?

An Angiopep-2–paclitaxel conjugate, also called paclitaxel trevatide.

81
New cards

Why may Angiopep-2 be useful for glioma targeting?

LRP-1 is overexpressed on glioma cell membranes.

82
New cards

What are two peptides targeting low-density lipoprotein related protein 1 (LRP-1)?

Angiopep-2 and aproprotein E derivatives

83
New cards

What does PTX stand for in the Angiopep-2 conjugate slides?

Paclitaxel.

84
New cards

What are some common linkers for peptide-drug conjugates?

Ester, amide, hydrazone, and disulfide

85
New cards

How many copies of drug can be attached in the illustrated Angiopep-2 conjugate design?

Three copies via the N-terminus and two lysine residues.

86
New cards

Name three peptides targeting transferrin-receptors

THR, CRT, HAI

87
New cards

How is the CRT peptide cyclized?

By a disulfide bond.

88
New cards

Why does CRT cyclization improve peptide stability?

It stabilizes the peptide to metabolism by proteases

89
New cards

Name 2 peptides that target ion channel receptors

RVG29 and apamin

90
New cards

What is RVG29?

A 29-amino-acid peptide sequence derived from rabies virus glycoprotein that targets the nicotinic acetylcholine receptor.

91
New cards

What has RVG29 been used to deliver?

Used for gene delivery

92
New cards

What is apamin?

A neurotoxin from bee venom that binds a potassium channel.

93
New cards

What is MiniAp-4?

A smaller lactam derivative of apamin that can deliver cargo across the BBB.

94
New cards

What peptide motif is used to target integrins?

RGD (Arg-Gly-Asp) peptides, typically as macrocyclic analogs.

95
New cards

What are common applications studied for RMT delivery?

Glioblastoma and other brain tumors, as well as neurodegenerative diseases.

96
New cards

What formulations are often combined with RMT peptides?

Nanoparticles and liposomes.

97
New cards

What is absorptive-mediated transcytosis (AMT)?

Uptake driven by electrostatic interaction of positively charged peptides with negatively charged cell-surface components, followed by endocytosis.

98
New cards

What negatively charged cell-surface components are mentioned in AMT?

Heparin proteoglycans.

99
New cards

What are cell-penetrating peptides (CPPs) generally like?

Highly basic, positively charged peptides.

100
New cards

What are some of the cell penetrating peptides that have been studied extensively?

Tat peptide, penetratin, polyarginine, SynB1